Literature DB >> 32071945

The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review.

Vanessa Pitz1, Naveed Malek2, Edward S Tobias3,4, Katherine A Grosset1,5, Steve Gentleman6, Donald G Grosset1,5.   

Abstract

BACKGROUND: A good response to levodopa is a key feature of Parkinson's disease (PD), and a poor response suggests an alternative diagnosis, but the extent of variation in the levodopa response in definite PD is not well defined. LITERATURE REVIEW: A systematic review of articles reporting pathologically confirmed PD and levodopa responsiveness from 1971 to 2018 was performed using the medical subheadings "postmortem," "Parkinson's disease," "levodopa," and "l-dopa" in PubMed, Embase, and Latin American and Caribbean Health Sciences Literature (LILACS) databases. CASES: A total of 12 articles described 445 PD cases: 61.7% male, age at disease onset 64.0 years (SD 9.6), age at death 77.1 years (SD 7.2). Levodopa responsiveness was reported in 399 cases (89.7%) either as a graded or a binary response. In the 280 cases (70.2%) describing a graded response, it was excellent in 37.5%, good in 45.7%, moderate in 12.1%, and poor in 4.6%. In the 119 cases describing a binary response (29.8%), 73.1% were levodopa responsive, and 26.9% were nonresponsive. Comorbid brain pathology was present in 137 of 235 cases assessed, being cerebrovascular in 46.0% and Alzheimer's disease in 37.2% of these, but its contribution to levodopa responsiveness was unclear.
CONCLUSIONS: The levodopa motor response varies in definite PD. Explanations other than diagnostic inaccuracy should be explored.
© 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  L‐dopa response; Parkinson's disease; pathological

Year:  2020        PMID: 32071945      PMCID: PMC7011806          DOI: 10.1002/mdc3.12885

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  22 in total

1.  Octogenarian parkinsonism - Clinicopathological observations.

Authors:  Ali H Rajput; Emma F Rajput
Journal:  Parkinsonism Relat Disord       Date:  2017-01-12       Impact factor: 4.891

2.  Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors.

Authors:  J N Joyce; H L Ryoo; T B Beach; J N Caviness; Mark Stacy; E V Gurevich; Mark Reiser; C H Adler
Journal:  Brain Res       Date:  2002-11-15       Impact factor: 3.252

3.  Sudden death in Parkinson's disease: a retrospective autopsy study.

Authors:  Hideyuki Matsumoto; Renpei Sengoku; Yuko Saito; Yukio Kakuta; Shigeo Murayama; Ichiro Imafuku
Journal:  J Neurol Sci       Date:  2014-06-02       Impact factor: 3.181

4.  Gender differences in Parkinson's disease.

Authors:  K E Lyons; J P Hubble; A I Tröster; R Pahwa; W C Koller
Journal:  Clin Neuropharmacol       Date:  1998 Mar-Apr       Impact factor: 1.592

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

Authors:  Eduardo De Pablo-Fernandez; Carmen Tur; Tamas Revesz; Andrew J Lees; Janice L Holton; Thomas T Warner
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

Review 7.  The effect of onset age on the clinical features of Parkinson's disease.

Authors:  M M Wickremaratchi; Y Ben-Shlomo; H R Morris
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

8.  A clinicopathologic study of 100 cases of Parkinson's disease.

Authors:  A J Hughes; S E Daniel; S Blankson; A J Lees
Journal:  Arch Neurol       Date:  1993-02

9.  Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease.

Authors:  G M Halliday; D A McRitchie; H Cartwright; R Pamphlett; M A Hely; J G Morris
Journal:  J Clin Neurosci       Date:  1996-01       Impact factor: 1.961

10.  'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia.

Authors:  R A de Vos; E N Jansen; F C Stam; R Ravid; D F Swaab
Journal:  Clin Neurol Neurosurg       Date:  1995-02       Impact factor: 1.876

View more
  3 in total

1.  Levodopa responsiveness in Parkinson's disease: harnessing real-life experience with machine-learning analysis.

Authors:  Ruth Djaldetti; Ben Hadad; Johnathan Reiner; Bella Askenazi Kharash; Boaz Lerner
Journal:  J Neural Transm (Vienna)       Date:  2022-08-27       Impact factor: 3.850

2.  Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson's disease.

Authors:  Nils Schröter; Michel Rijntjes; Horst Urbach; Cornelius Weiller; Martin Treppner; Elias Kellner; Wolfgang H Jost; Bastian E A Sajonz; Marco Reisert; Jonas A Hosp; Alexander Rau
Journal:  NPJ Parkinsons Dis       Date:  2022-10-14

Review 3.  Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's Perspective.

Authors:  Roger A Barker; Emma V Cutting; Danielle M Daft
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.